Albert Qin

14PUBLICATIONS
15CO-AUTHORS
HaematologyMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 17, 2026
Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.

|Mar 02, 2026
Beyond Oncogenes: Selectively Targeting Whole-Tumor Cell Growth Regulation.

Albert Qin

|May 02, 2025
Population Pharmacokinetics-Pharmacodynamics and Exposure-Response of Ropeginterferon Alfa-2b in Chinese and Japanese Patients With Polycythemia Vera.

Albert Qin, Kazuya Shimoda, Shanshan Suo

|Sep 14, 2024
A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer.

Xu Xu, Shih-Long Yan, Yi-Te Yo

|May 25, 2024
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study.

David Wang, Natalie Hughes-Medlicott, Lilian Klingler

|Mar 19, 2024
Exposure-efficacy and exposure-safety analyses of ropeginterferon alfa-2b treatment in patients with polycythaemia vera.

Albert Qin, Daoxiang Wu, Yaning Li

Pageof 3

Frequent Collaborators

2 joint publications

Jie Jin

2 joint publications

Lei Zhang

2 joint publications

Minghui Duan

2 joint publications

Sujiang Zhang